During 2022, the VHIR microbiology research group has continued promoting its research on the study of the microbiology aspects involved in the infectious diseases improving its own research and collaboration with other hospital, primary health care and clinical research groups, as well as with the industry to potentiate the translation and exploitation of its research. We have worked with special interest in studying the mechanisms involved in antimicrobial resistance and nosocomial infection, the viral respiratory infection diseases, the microbial surveillance and characterization of emerging and re-emerging pathogens, the viral and fungal infection in immunocompromised patients, the sexually transmitted infectious diseases and in global health.

Group Leader
Juan Jose Gonzalez Lopez

Principal Investigator (PI)
Andrés Antón Pagarolas, Joan Joseph Munné, Juan José González López, María Nieves Larrosa Escartín, Tomàs Pumarola Suñé

Researchers
Alba Mir Cros, Ariadna Rando Segura, Aroa Silgado Giménez, Belén Viñado Pérez, Cristina Andrés Vergés, Daniel Romero Herrero, David Tabernero Caellas, Elena Sulleiro Igual, Juliana Esperalba Esquerra, Lidia Goterris Bonet, Maria Francesca Cortese, Maria Piñana Moro, Maria Teresa Martín Gómez, María Teresa Tórtola Fernández, Mayli Lung Suárez, Narcís Saubí Roca, Paula Salmerón Menéndez, Rosa Maria Bartolomé Comas, Virgínia Rodríguez Garrido, Yannick Hoyos Mallecot

PhD Students
Albert Moreno Mingorance, Alejandra González Sánchez, Beatriz Pacín Ruiz, Josep Roca Grande, Maria Arnedo Muñoz, Selene Garcia Garcia

87

PUBLICATIONS

57.5%

%Q1

798

IMPACT FACTOR

9.18

AVERAGE IMPACT FACTOR

SELECTED ARTICLES

Mir-Cros A, Moreno-Mingorance A, Martín-Gómez MT, Abad R, Bloise I, Campins M, González-Praetorius A, Gutiérrez MN, Martín-González H, Muñoz-Almagro C, Orellana MÁ, de Pablos M, Roca-Grande J, Rodrigo C, Rodríguez ME, Uriona S, Vidal MJ, Pumarola T, Larrosa MN, González-López JJ
Pertactin-Deficient Bordetella pertussis with Unusual Mechanism of Pertactin Disruption, Spain, 1986-2018
Emerg Infect Dis. 2022 May;28(5):967-976
DOI: DOI: 10.3201/eid2805.211958
IF: 16.13

Andres C, Vila J, Creus-Costa A, Pinana M, Gonzalez-Sanchez A, Esperalba J, Codina MG, Castillo C, Martin MC, Fuentes F, Rubio S, Garcia-Comunas K, Vasquez-Mercado R, Saubi N, Rodrigo C, Pumarola T, Anton A
Enterovirus D68 in Hospitalized Children, Barcelona, Spain, 2014-2021
Emerg Infect Dis. 2022 Jul;28(7):1327-1331
DOI: DOI: 10.3201/eid2807.220264
IF: 16.13

Silgado A, Bosch-Nicolau P, Sánchez-Montalvá A, Cervià A, Gomez-I-Prat J, Bagaria G, Rodriguez C, Goterris L, Serre-Delcor N, Oliveira-Souto I, Salvador F, Molina I, Sulleiro E
Opportunistic Community Screening of Chronic Chagas Disease Using a Rapid Diagnosis Test in Pharmacies in Barcelona (Catalonia, Spain): Study Protocol and Pilot Phase Results
Int J Public Health . 2022 Nov 30;67:1605386
DOI: DOI: 10.3389/ijph.2022.1605386
IF: 5.10

Chen CW, Saubi N, Kilpeläinen A, Joseph-Munné J
Chimeric Human Papillomavirus-16 Virus-like Particles Presenting P18I10 and T20 Peptides from HIV-1 Envelope Induce HPV16 and HIV-1-Specific Humoral and T Cell-Mediated Immunity in BALB/c Mice
Vaccines (Basel) . 2022 Dec 21;11(1):15
DOI: DOI: 10.3390/vaccines11010015
IF: 4.96

Andres C, Pinana M, Borras-Bermejo B, Gonzalez-Sanchez A, Garcia-Cehic D, Esperalba J, Rando A, Zules-Ona RG, Campos C, Codina MG, Blanco-Grau A, Colomer-Castell S, Martin MC, Castillo C, Garcia-Comunas K, Vasquez-Mercado R, Martins-Martins R, Campins-Marti M, Pumarola T, Quer J, Anton A
A year living with SARS-CoV-2: an epidemiological overview of viral lineage circulation by whole-genome sequencing in Barcelona city (Catalonia, Spain)
Emerg Microbes Infect. 2022 Dec;11(1):172-181
DOI: DOI: 10.1080/22221751.2021.2011617
IF: 19.60

Development of a new intelligent and predictive tool for the early diagnosis and improved treatment of sepsis
Principal Investigator: Juan José González López
Agency: Ministerio de Ciencia e Innovación (MICINN)
Funding: 339.371 €
Period: 2022-2025

Virus Respiratorio Sincitial (VRS). Estudio de las características del virus, del huésped, y los factores ambientales como determinantes de la epidemia y su gravedad clínica.
Principal Investigator: Tomàs Pumarola Suñé
Agency: Instituto de Salud Carlos III (ISCIII)
Funding: 93.170€
Period: 2019-2022

Pre-clinical evaluation of safety and immunogenicity of recombinant BCG expressing SIV:consv in Cynomolgus macaques. A new platform for a bivalent HIV/TB vaccine development
Principal Investigator: Joan Joseph Munné
Agency: Instituto de Salud Carlos III (ISCIII)
Funding: 147.620€
Period: 2021-2023

European AIDS Vaccine Initiative 2020 (EAVI2020)
Principal Investigator: Joan Joseph Munné
Agency: European Comission
Funding: 195.315,65€
Period: 2019-2022

PHITBAC – Biosensores nanofotónicos para el diagnóstico y gestión clínica de infecciones bacterianas en el punto de atención
Principal Investigator: Juan José González López
Agency: Ministerio de Ciencia e Innovación (MICINN)
Funding: 115.970€
Period: 2021-2024

Reagents and fast methods for pathogen characterization and serology testing
Priority Number: EP19382496.8
Priority Date: 13/06/2019
Applicants: 100% FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

Reagents and fast methods for pathogen characterization and serology testing
Priority Number: PCT/EP2020/066292
Priority Date: 12/06/2020
Applicants: 100% FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA

Reagents and fast methods for pathogen characterization and serology testing
Priority Number: P5073US00, 17/618,837
Priority Date: 13/12/2021
Applicants: 100% FUNDACIÓ HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA